These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 2897281
1. [Neurotic inhibition and transnosographic approach. Apropos of a multicenter study of carpipramine]. Ferreri M, Alby JM. Encephale; 1987; 13(6):357-65. PubMed ID: 2897281 [Abstract] [Full Text] [Related]
4. [Carpipramine]. des Lauriers A, Clery-Melin P, Allilaire JF, Baruch P, Ammar S, Vilamot B. Encephale; 1990; 16(1):53. PubMed ID: 2328685 [No Abstract] [Full Text] [Related]
5. [The role of bemitil pharmacokinetics in realizing its therapeutic efficacy]. Boĭko SS, Zherdev VP, Neznamov GG. Farmakol Toksikol; 1991; 54(2):64-6. PubMed ID: 1679400 [Abstract] [Full Text] [Related]
6. [The correlation of the electroencephalographic and clinical effects of benzodiazepine tranquilizers in patients with mental disorders at the neurotic level]. Bochkarev VK, Neznamov GG. Eksp Klin Farmakol; 1995; 58(4):18-22. PubMed ID: 7580745 [No Abstract] [Full Text] [Related]
7. [Open clinical trial with pinazepam]. Corni L, Palmarin R. Clin Ter; 1976 Aug 15; 78(3):219-26. PubMed ID: 12907 [No Abstract] [Full Text] [Related]
8. Clinical experience with carpipramine (Defekton). Pislová J, Pisl I, Petránová T, Petrová M. Act Nerv Super (Praha); 1974 Aug 15; 16(3):168-9. PubMed ID: 4608287 [No Abstract] [Full Text] [Related]
10. [Carpipramine (Prazinil) in ambulatory psychiatry. Trials and clinical prospects]. Perier M, Peyrouzet JM. Ann Med Psychol (Paris); 1978 May 15; 136(5):816-24. PubMed ID: 369429 [No Abstract] [Full Text] [Related]
11. [Double blind comparative clinical evaluation of a new anxiolytic agent, Zami-905: propazepam]. Carbonell Masía DC, Calvé Pérez A. Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1976 May 15; 4(6):377-86. PubMed ID: 19933 [No Abstract] [Full Text] [Related]
12. [Tranquilizers in the combined treatment of patients with arterial hypertension]. Vanchakova NP, Skvortsov NL. Vrach Delo; 1988 Aug 15; (8):48-50. PubMed ID: 2905095 [No Abstract] [Full Text] [Related]
17. [Use of psychophysiologic indices for the prognosis of the clinical action of tranquilizers]. Aleksandrovskiĭ IuA, Ben'kovich BI, Marshak OV. Zh Nevropatol Psikhiatr Im S S Korsakova; 1988 Aug 15; 88(12):90-8. PubMed ID: 2907706 [Abstract] [Full Text] [Related]
19. [The effect of an inhibition-counteracting agent in the adolescent]. Danjoux J, Moron P. Neuropsychiatr Enfance Adolesc; 1979 Jun 15; 27(6):293-7. PubMed ID: 530420 [No Abstract] [Full Text] [Related]
20. Therapy of neurotic and pseudoneurotic symptoms with tofisopam. Libus J, Libusova E. Agressologie; 1981 Nov 15; 22(D):21-2. PubMed ID: 6120662 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]